Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
The state of Wisconsin offers a substantial healthcare network and renowned medical research institutions, making it a prime location for clinical research into a variety of conditions. Leading centers such as the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and Froedtert Hospital are state leaders in medical research. These institutions, known for their innovative approaches, provide a strong foundation for conducting clinical trials that advance medical knowledge and treatment options.
Why choose Wisconsin for clinical trials?
There are several reasons why researchers conduct clinical trials in Wisconsin. Firstly, the state’s diverse population provides a wide range of participants, which enhances the accuracy and applicability of research outcomes. Wisconsin is also home to a thriving research community, with a strong emphasis on medical innovation and innovative studies that push boundaries.
By choosing to participate in a clinical trial in Wisconsin, you play a crucial role in advancing medical research while benefiting from a well-established and supportive clinical research environment, backed by renowned institutions and expert healthcare professionals.
Common conditions studied in Wisconsin
The state of Wisconsin is recognized for its contributions to clinical research in several key medical fields.
Pediatric conditions
The Children’s Hospital of Wisconsin is a leader in pediatric research, conducting clinical trials on a variety of childhood diseases. Trials cover conditions like cystic fibrosis, where researchers test new treatments aimed at improving lung function and overall health.
Studies also focus on managing asthma through innovative inhalers and medications, and genetic disorders, where gene therapies and new diagnostic techniques are explored to provide better outcomes for children.
Cardiovascular disease
Cardiovascular health is a significant concern in Wisconsin, prompting extensive research into heart disease. Major institutions like the Medical College of Wisconsin lead clinical trials on new pharmacological treatments, lifestyle modifications, and interventional procedures aimed at reducing heart disease risk.
Studies often investigate the effectiveness of medical devices such as stents and pacemakers, and research into preventive measures is critical, given the high prevalence of obesity and hypertension in the region.
Diabetes
Wisconsin’s research into diabetes addresses both Type 1 and Type 2 diabetes, focusing on developing innovative insulin therapies and oral medications that enhance glycemic control.
Trials often involve lifestyle interventions, such as diet and exercise programs, to evaluate their effectiveness in managing blood sugar levels. Additionally, researchers explore the genetic and environmental factors contributing to diabetes prevalence, aiming to improve preventive strategies.
Neurological disorders
The state of Wisconsin is a hub for research into neurological disorders, particularly at the Wisconsin Alzheimer’s Disease Research Center. Clinical trials aim to discover new drugs to slow disease progression in Alzheimer’s and Parkinson’s patients, as well as approaches to enhance cognitive function. Research also investigates biomarkers for early diagnosis and the potential benefits of lifestyle modifications, such as exercise and diet, in managing neurological health.
Autoimmune diseases
Wisconsin's focus on autoimmune diseases includes extensive research into rheumatoid arthritis, lupus, and multiple sclerosis (MS). Clinical trials test new biologic agents that target specific immune pathways to reduce inflammation and disease symptoms.
The state’s medical institutions also explore the psychosocial aspects of living with chronic autoimmune conditions, aiming to develop comprehensive care strategies that address both physical and emotional well-being.
Cancer
Wisconsin's commitment to cancer research is exemplified by the University of Wisconsin Carbone Cancer Center, which is recognized for its innovative approaches to treating various cancer types. Ongoing oncology clinical trials here explore novel therapies, including immunotherapies that harness the body’s immune system to fight cancer, and targeted therapies that aim to attack specific cancer cells.
Research in Wisconsin also focuses on improving early detection methods and enhancing patient quality of life during treatment. These efforts are crucial in a state where cancer remains a leading cause of death.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Local regulations and guidelines
In Wisconsin, clinical trials are governed by a combination of federal and state regulations that ensure participant safety and good ethical conduct. The primary regulatory body is the U.S. Food and Drug Administration (FDA), which oversees clinical trial protocols, informed consent, and the use of investigational drugs. Additionally, all research involving human subjects must comply with the guidelines established by the Institutional Review Boards (IRBs) at the participating institutions.
Wisconsin also adheres to the Common Rule, a federal policy that sets standards for the ethical treatment of research subjects, including requirements for informed consent and monitoring of ongoing studies.
State laws may impose additional protections, especially for vulnerable populations such as minors or individuals with diminished capacity. Researchers must also register their trials on ClinicalTrials.gov, providing transparency and access to information for potential participants.
Benefits of participating in clinical trials
Volunteering in a clinical trial presents a valuable chance for individuals to experience innovative treatments and therapies before they become widely accessible. This is particularly important for those whose conditions have not improved with standard medical interventions. During the trial, participants benefit from the expertise of dedicated healthcare professionals who provide tailored care and rigorous monitoring, ensuring both safety and effectiveness throughout the process.
Moreover, involvement in clinical trials is essential for the progress of medical research. These studies frequently result in significant advancements in treatment methodologies and health strategies. By participating, individuals not only gain early access to transformative care but also play a crucial role in advancing scientific knowledge, ultimately influencing the future of healthcare and enhancing outcomes for patients everywhere.
How to enroll in a clinical trial in Wisconsin
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.